PharmTech Multimedia
Dennis Brandl, President, at BR&L Consulting, spoke with Pharmaceutical Technology about what should be expected when transitioning from paper to EBR.
Dennis Brandl, President, at BR&L Consulting, spoke with Pharmaceutical Technology about what should be expected when transitioning from paper to EBR.